CAS 198481-33-3
:Bazedoxifene acetate
Description:
Bazedoxifene acetate is a selective estrogen receptor modulator (SERM) primarily used in the treatment of postmenopausal osteoporosis and for the management of menopausal symptoms. It functions by mimicking estrogen in certain tissues, such as bone, while acting as an estrogen antagonist in others, such as breast and uterine tissues, thereby reducing the risk of estrogen-related side effects. The compound is characterized by its ability to bind selectively to estrogen receptors, promoting bone density without stimulating breast or uterine tissue proliferation. Bazedoxifene acetate is typically administered orally and is often combined with conjugated estrogens in therapeutic regimens. Its pharmacokinetics indicate a favorable absorption profile, with metabolism primarily occurring in the liver. The substance is known for its efficacy in reducing the incidence of vertebral fractures and improving overall bone health in postmenopausal women. As with any medication, potential side effects may include hot flashes, muscle spasms, and gastrointestinal disturbances, necessitating careful consideration of patient history and risk factors before prescribing.
Formula:C30H34N2O3·C2H4O2
InChI:InChI=1S/C30H34N2O3.C2H4O2/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31;1-2(3)4/h6-15,20,33-34H,2-5,16-19,21H2,1H3;1H3,(H,3,4)
InChI key:InChIKey=OMZAMQFQZMUNTP-UHFFFAOYSA-N
SMILES:C(N1C(=C(C)C=2C1=CC=C(O)C2)C3=CC=C(O)C=C3)C4=CC=C(OCCN5CCCCCC5)C=C4.C(C)(O)=O
Synonyms:- 1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol acetate
- 1-(p-(2-(Hexahydro-1H-azepin-1-yl)ethoxy)benzyl)-2-(p-hydroxyphenyl)-3-methylindol-5-ol monoacetate (salt)
- 1-{4-[2-(azepan-1-yl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol acetate (1:1)
- 1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-, monoacetate (salt)
- 1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-, acetate (1:1)
- Tse 424
- Unii-J70472Ud3D
- Viviant
- Way-140424
- Way-Tes 424
- Bazedoxifene acetate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-, acetate (1:1)
CAS:Formula:C32H38N2O5Purity:98%Color and Shape:SolidMolecular weight:530.6545Bazedoxifene Acetate
CAS:Formula:C30H34N2O3·C2H4O2Color and Shape:Off-White SolidMolecular weight:470.61 60.05Bazedoxifene acetate
CAS:Formula:C30H34N2O3·C2H4O2Purity:(HPLC) ≥ 98.0%Color and Shape:White to beige powderMolecular weight:530.64Bazedoxifene Acetate
CAS:Controlled ProductFormula:C30H34N2O3·C2H4O2Color and Shape:NeatMolecular weight:530.65Bazedoxifene acetate
CAS:<p>Bazedoxifene acetate (WAY-TES 424) is a novel selective estrogen receptor modulator (SERM).</p>Formula:C32H38N2O5Purity:99.24%Color and Shape:SolidMolecular weight:530.67Bazedoxifene Acetate
CAS:<p>Applications Bazedoxifene Acetate is a nonsteroidal selective estrogen receptor modulator (SERM). Bazedoxifene Acetate is used as an antiosteoporotic.<br>References van Hoorn, W., et al.: J. Med. Chem., 45, 584 (2002); Neubauer, B., et al.: Cancer Res., 63, 6056 (2003); Yan, X., et al.: Biochemistry, 43, 909 (2004);<br></p>Formula:C30H34N2O3·C2H4O2Color and Shape:NeatMolecular weight:530.65Bazedoxifene acetate
CAS:Controlled Product<p>Bazedoxifene acetate is a selective estrogen receptor modulator (SERM) that prevents bone loss and reduces the risk of breast cancer in postmenopausal women. Bazedoxifene acetate has been shown to be safe and effective for the treatment of endometriosis, as it inhibits the growth of uterine tissue outside the uterus. Bazedoxifene acetate also acts on estrogen receptors in breast tissue and may be used to prevent breast cancer.</p>Formula:C32H38N2O5Purity:Min. 95%Color and Shape:White PowderMolecular weight:530.65 g/mol








